Torrent Pharmaceuticals Limited (NSE:TORNTPHARM)

Market Cap	1.07T
Revenue (ttm)	115.16B
Net Income (ttm)	19.11B
Shares Out	n/a
EPS (ttm)	56.47
PE Ratio	56.12
Forward PE	42.91
Dividend	32.00 (1.01%)
Ex-Dividend Date	Jun 20, 2025

Volume	15,370
Average Volume	333,278
Open	3,146.20
Previous Close	3,167.20
Day's Range	3,146.20 - 3,170.10
52-Week Range	2,755.90 - 3,590.70
Beta	0.16
RSI	44.26
Earnings Date	Jul 28, 2025

About Torrent Pharmaceuticals

Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, and marketing of generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally. The company offers products in various therapeutic areas, including cardiovascular, central nervous system, gastro-intestinal, and women healthcare; and dermatology, diabetology, pain management, gynecology, oncology, and anti-infective, as well as vitamins, minerals, and nutrients. It also provides contract manufacturing services. The company...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1959
• Employees: 15,718
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: TORNTPHARM

Financial Performance

In 2024, Torrent Pharmaceuticals's revenue was 115.16 billion, an increase of 7.35% compared to the previous year's 107.28 billion. Earnings were 19.11 billion, an increase of 15.37%.